Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
729
NCT02147899
A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis
Phase: Phase 2
Role: Lead Sponsor
Start: May 31, 2014
Completion: Oct 31, 2014
NCT02418845
A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis
Phase: Phase 3
Start: May 28, 2015
Completion: Dec 5, 2015
NCT02452866
Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219
Start: Jun 30, 2015
Completion: Oct 31, 2015